FELOCELL 3 VACCINE

Indications

• Measles
• Mumps
• Rubella
• Yellow fever
• Varicella (chickenpox)
• Rotavirus

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing.

Adults: Refer to specific vaccine guidelines for adult dosing.

Mechanism of action

Attenuated vaccines work by mimicking a natural infection. The weakened pathogen replicates in the body, stimulating the immune system to produce a response against it, which includes the activation of T-cells and the production of antibodies. This prepares the immune system to recognize and fight off the pathogen if exposed in the future.

Pharmacodynamics

The pharmacodynamics of attenuated vaccines involve the interaction of the attenuated pathogen with the host's immune system. Upon administration, the vaccine induces both humoral (antibody-mediated) and cell-mediated immunity. This leads to the development of memory cells that ensure a faster and more effective response upon subsequent exposure to the actual pathogen.

Pharmacokinetics

Attenuated vaccines are generally administered via subcutaneous or intramuscular injection. The pharmacokinetics are characterized by the distribution of the vaccine components within the body, with the attenuated organisms replicating locally and inducing an immune response. The onset of immunity typically occurs within weeks, and the duration of immunity can vary depending on the specific vaccine.

Contra-indications

• Severe immunodeficiency
• Pregnant women (specific live attenuated vaccines)
• Severe allergic reactions to vaccine components

Adverse effects

• Injection site reactions (pain, swelling, redness)
• Low-grade fever
• Malaise
• Rash
• Rare neurological complications (e.g., Guillain-Barré syndrome)

Interactions

• Immunosuppressive agents (may reduce vaccine efficacy)
• Blood products (may interfere with immune response to vaccine)
• Other live vaccines (timing may affect immune response)

Precautions

• History of allergic reactions to previous vaccinations
• Presence of active infections
• Chronic illnesses that may affect immune response

Pregnancy

Live attenuated vaccines are generally contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Most live attenuated vaccines are considered safe during breastfeeding, but caution and consultation with a healthcare provider are advised.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Injectable suspension
• Oral suspension
• Lyophilized powder for reconstitution

Indications

• Viral gastroenteritis
• Foodborne illness outbreaks
• Acute gastroenteritis in children and adults

Dosage

Children: No specific dosage information available as calicivirus is a viral pathogen and not a pharmacological agent. Supportive care is recommended.

Adults: No specific dosage information available as calicivirus is a viral pathogen and not a pharmacological agent. Supportive care is recommended.

Mechanism of action

Calicivirus primarily targets epithelial cells in the intestine. The virus attaches to specific receptors on the surface of these cells, facilitating entry and subsequent replication. Once inside the host cell, the viral RNA is released and hijacks the host's cellular machinery to produce viral proteins, leading to the assembly of new virions and cell lysis. This process disrupts normal intestinal function, resulting in the characteristic symptoms of gastroenteritis.

Pharmacodynamics

The pharmacodynamics of calicivirus involves its ability to replicate within host cells, leading to cell death and inflammation of the intestinal lining. This inflammation is responsible for the symptoms associated with infection, such as diarrhea and vomiting. The immune response to the infection also plays a role in symptom severity and duration, with cytokine release contributing to gastrointestinal distress.

Pharmacokinetics

As a virus, calicivirus does not undergo classical pharmacokinetics like traditional drugs. Instead, its replication cycle involves attachment, entry, and release processes within host cells. The duration of illness caused by calicivirus typically lasts between 24 to 48 hours, with the virus being shed in the feces during this time, facilitating transmission to others.

Pregnancy

There is limited data on the effects of calicivirus in pregnancy. Consult healthcare providers for specific cases.

Breast-feeding

The safety of calicivirus during breastfeeding is not well established. Consult healthcare providers for recommendations.

Storage

Store at room temperature, away from direct sunlight and moisture. Refer to specific product guidelines for detailed storage instructions.

Indications

• Bacterial infections
• Pain management
• Anesthesia for surgical procedures
• Chronic inflammatory conditions
• Anxiety and behavioral issues

Dosage

Children: Refer to specific drug indications and guidelines as dosages vary widely by medication.

Adults: Refer to specific drug indications and guidelines as dosages vary widely by medication.

Mechanism of action

The mechanisms of action for feline medications vary widely depending on the drug class. For instance, antibiotics work by inhibiting bacterial growth or killing bacteria, while analgesics may block pain signals in the nervous system or reduce inflammation. Additionally, some drugs modulate neurotransmitter levels to alleviate conditions like anxiety or depression in felines.

Pharmacodynamics

Pharmacodynamics in feline medications includes understanding how the drugs affect the body, including their efficacy and the onset of action. For example, analgesics may provide rapid relief from pain, whereas antibiotics may require several days of treatment to fully eradicate an infection. The response to these medications can vary based on the individual cat's health status, age, and concurrent diseases.

Pharmacokinetics

Pharmacokinetics of feline drugs involves the absorption, distribution, metabolism, and excretion of medications. Cats often metabolize drugs differently than other species; for instance, they have a unique liver enzyme profile that affects drug metabolism. This can lead to variations in drug half-lives and the need for adjusted dosing regimens. Additionally, factors like age, liver function, and hydration status can influence pharmacokinetics in cats.

Indications

• Herpes Simplex Virus infection
• Genital herpes
• Cold sores
• Varicella (chickenpox)
• Herpes Zoster (shingles)
• Prevention of herpes virus reactivation in immunocompromised patients

Dosage

Adults: Refer to the BNF for specific dosing recommendations for adults

Mechanism of action

Herpesvirus antiviral medications, such as acyclovir and valacyclovir, primarily inhibit viral DNA synthesis. They are nucleoside analogs that get incorporated into the growing viral DNA chain, leading to premature termination of DNA synthesis. This action is selective for infected cells, as the drugs are activated by viral thymidine kinase, which is present in infected cells but absent in uninfected cells.

Pharmacodynamics

The pharmacodynamic profile of herpesvirus antivirals shows that they are more effective when administered early in the course of the infection. Acyclovir exhibits a higher affinity for viral DNA polymerase than for the host cell's enzymes, which reduces toxicity to human cells. The efficacy of these medications is related to the degree of viral replication; higher viral loads may require higher doses or more frequent administration.

Pharmacokinetics

Acyclovir is well absorbed after oral administration, with a bioavailability of approximately 15-30%. It is widely distributed in body fluids and tissues, including the central nervous system. It undergoes renal excretion, primarily as unchanged drug, necessitating dosage adjustment in patients with renal impairment. The half-life of acyclovir ranges from 2.5 to 3 hours in healthy adults, but this can be prolonged in cases of renal dysfunction. Valacyclovir, a prodrug of acyclovir, has improved bioavailability of approximately 54% and is converted to acyclovir in the body.

Contra-indications

• Hypersensitivity to acyclovir or any of its components
• Severe renal impairment

Adverse effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Rash
• Renal toxicity
• Neurotoxicity (in cases of rapid infusion or dehydration)

Interactions

• Probenecid may reduce renal clearance of acyclovir
• Other nephrotoxic agents may increase the risk of renal impairment
• Zidovudine may increase the risk of hematological toxicity

Precautions

• Monitor renal function during treatment, especially in patients with pre-existing renal disease
• Hydration is important to prevent crystallization in the kidneys
• Use caution in patients with neurological conditions

Pregnancy

Acyclovir is classified as a category B drug. Animal studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.

Breast-feeding

Acyclovir is excreted in breast milk in small amounts. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Oral tablets
• Topical cream
• Intravenous injection
• Oral suspension

Indications

• Supportive care for feline panleukopenia
• Management of dehydration
• Management of secondary infections

Dosage

Children: Refer to veterinary guidelines for supportive care and symptomatic treatment, as specific dosing will depend on the medications used.

Adults: Refer to veterinary guidelines for supportive care and symptomatic treatment, as specific dosing will depend on the medications used.

Mechanism of action

Feline panleukopenia virus primarily targets and replicates in rapidly dividing cells, such as those in the bone marrow and intestines. The virus interferes with the normal functioning of the host cells, leading to cell death and a significant decrease in leukocyte levels, particularly lymphocytes and neutrophils, resulting in panleukopenia.

Pharmacodynamics

The pharmacodynamics of managing panleukopenia involve supportive care and symptomatic treatment, as there is no specific antiviral treatment for the virus. Supportive care may include fluid therapy to combat dehydration, nutritional support, and antibiotics to prevent or treat secondary bacterial infections due to the compromised immune system.

Pharmacokinetics

Pharmacokinetic data specific to feline panleukopenia is not typically applicable as the management focuses on symptomatic and supportive care rather than pharmacological interventions. Any medications used in management would follow standard pharmacokinetic principles such as absorption, distribution, metabolism, and excretion based on the specific agents employed.

Pregnancy

Safety in pregnancy is not established, consult healthcare providers for risk assessment.

Breast-feeding

Safety during breastfeeding is unclear, consult healthcare providers for guidance.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Muscle strain
• Tendon strain
• Acute pain management
• Inflammation control

Dosage

Children: Refer to specific medication guidelines as dosing varies by drug used for pain management.

Adults: Refer to specific medication guidelines as dosing varies by drug used for pain management.

Mechanism of action

The mechanism of injury in strains involves the disruption of muscle fibers or tendons due to excessive tension or force. This can lead to inflammation, pain, and impaired function. Inflammatory mediators are released at the site of injury, resulting in local vasodilation, increased permeability of blood vessels, and recruitment of immune cells which contribute to the healing process.

Pharmacodynamics

The pharmacodynamics of treating strains often involve the use of analgesics and anti-inflammatory medications, which work by inhibiting cyclooxygenase (COX) enzymes, leading to decreased production of prostaglandins. This reduces pain and inflammation associated with muscle or tendon injury. Physical therapy may also play a significant role in enhancing recovery and restoring function.

Pharmacokinetics

The pharmacokinetics of medications used for strains, such as NSAIDs, vary depending on the specific drug. Generally, these agents are absorbed rapidly from the gastrointestinal tract, peak in plasma concentration within a few hours, and have a half-life that varies widely. Metabolism typically occurs in the liver, and excretion is primarily via the kidneys. Individual responses can vary based on age, weight, and overall health.

Pregnancy

Consult healthcare provider before use.

Breast-feeding

Consult healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.